Human Breast Cancer Cells Are Redirected to Mammary Epithelial Cells upon Interaction with the Regenerating Mammary Gland Microenvironment In-Vivo

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Bussard, Karen M ^a   Smith, Gilbert H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LACTALBUMIN; CYTOKERATIN 14; CYTOKERATIN 8;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CANCER TRANSPLANTATION; CELL FATE; CELL INTERACTION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAMMARY GLAND; METAPHASE; MITOCHONDRION; MOUSE; NONHUMAN; ORGANOGENESIS; PROGENY;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM TRANSPLANTATION;

EID: 84869109347     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049221     Document Type: Article

References (38)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Lorusso G, Ruegg C, (2008) The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 130: 1091-1103.
3. Mintz B, Illmensee, (1975) Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A 72: 3585-3589.
4. Illmensee K, Mintz B, (1976) Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc Natl Acad Sci U S A 73: 549-553.
5. Felsher DW, (2003) Cancer revoked: Oncogenes as therapeutic targets. Nat Rev Cancer 3: 375-380.
6. Hochedlinger K, Blelloch R, Brennan C, Yamada Y, Kim M, et al. (2004) Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev 18: 1875-1885.
7. Bussard KM, Boulanger CA, Booth BW, Bruno RD, Smith GH, (2010) Reprogramming human cancer cells in the mouse mammary gland. Cancer Res 70: 6336-6343.
8. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, et al. (1984) Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in-vivo and in-vitro. Lab Invest 50: 147-162.
9. Cailleau R, Olive M, Cruciger QV, (1978) Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14: 911-915.
10. Phadke PA, Vaidya KS, Nash KT, Hurst DR, Welch DR, (2008) BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. Am J Pathol 172: 809-817.
11. Seraj MJ, Samant RS, Verderame MF, Welch DR, (2000) Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q131. Cancer Res 60: 2764-2769.
12. Shay JW, Wright WE, Brasiskyte D, Van der Haegen BA, (1993) E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene 8: 1407-1413.
13. Clontech (2000) Infinity human mammary epithelial cell line. CLONTECHniques 15: 12-13.
14. Spector DL, Goldman RD, Leinwand LA (1998) Cells: a laboratory manual. New York: Cold Spring Harbor Laboratory Press.
15. Ip MM, Asch BB (2000) Methods in mammary gland biology and breast cancer research. New York: Kluwer Academic.
16. Smith GH, Mehrel T, Roop DR, (1990) Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mosue mammary epithelium. Cell Growth and Differentiation 1: 161-170.
17. Smith GH, Vonderhaar BK, Graham DE, Medina D, (1984) Expression of pregnancy-specific genes in preneoplastic mouse mammary tissues from virgin mice. Cancer Res 44: 3426-3437.
18. Bussard KM, Okita N, Sharkey N, Neuberger T, Webb A, et al. (2010) Localization of osteoblast inflammatory cytokines MCP-1 and VEGF to the matrix of the trabecula of the femur, a target area for metastatic breast cancer cell colonization. Clin Exp Metastasis 27: 331-340.
19. Telenius H, Pelmear AH, Tunnacliffe A, Carter NP, Behmel A, et al. (1992) Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer 4: 257-263.
20. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, et al. (1992) Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 13: 718-725.
21. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, et al. (2005) Isolation and in- vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511.
22. Smith GH, (1996) Experimental mammary epithelial morphogenesis in an in-vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res Treat 39: 21-31.
23. Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
24. Marx J, (2003) Mutant stem cells may seed cancer. Science 301: 1308-1310.
25. Pardal R, Clarke MF, Morrison SJ, (2003) Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3: 895-902.
26. Park CH, Bergsagel DE, McCulloch EA, (1971) Mouse myeloma tumor stem cells: a primary cell culture assay. J Nat Cancer Institute 46: 411-422.
27. Bonnet D, Dick JE, (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737.
28. Zhang QB, Ji X, Huang Q, Dong J, Zhu YD, et al. (2006) Differentiation profile of brain tumor stem cells: a comparative study with neural stem cells. Cell Research 16: 909-915.
29. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
30. Visvader JE, Lindeman GJ, (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
31. Ginester C, Wicinski J, Cervera N, Monville F, Finetti P, et al. (2009) Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 8: 3297-3302.
32. Jones JL, Royall JE, Critchley DR, Walker RA, (1997) Modulation of myoepithelial-associated α6β4 integrin in a breast cancer cell line alters invasive potential. Exp Cell Res 235: 325-333.
33. Agrawal G, Chen JH, Baick CH, Chen AE, Mehta RS, et al. (2007) Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy. J Clin Oncol 25: 2618-2620.
34. Bussard KM, Smith GH, (2011) The mammary gland microenvironment directs progenitor cell fate in-vivo. Int J Cell Biol 451676: 1-11.
35. Peirce SK, Chen WY, (2005) Quantification of prolactin receptor mRNA in mulitple human tissues and cancer cells lines by real time RT-PCR. J Endocrinol 171: R1-R4.
36. Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, et al. (2011) Distinct stem cells contribute to mammary gland development and maintenance. Nature 479: 189-195.
37. Nouhi Z, Chughtai N, Hartley S, Cocolakis E, Lebrun JJ, et al. (2006) Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells. Cancer Res 66: 1824-1832.
38. Louderbough JMV, Schroeder JA, (2011) Understanding the dual nature of CD44 in breast cancer progression. Mol Cancer Res 9: 1573-1586.